FAILED
首站-论文投稿智能助手
典型文献
Association between time in range and cancer mortality among patients with type 2 diabetes: a prospective cohort study
文献摘要:
Background::Little was known about the association among time in range (TIR), time above range (TAR), time below range (TBR), and cancer mortality among patients with type 2 diabetes. We aimed to investigate the association among TIR, TAR, TBR, and the risk of cancer mortality among patients with type 2 diabetes.Methods::A total of 6225 patients with type 2 diabetes were prospectively recruited in Shanghai, China. TIR was measured with continuous glucose monitoring at baseline and was defined as the average percentage of time in the target glucose range during a 24 h period. Cox proportion hazard regression analysis was used to determine the association between TIR and the risk of cancer mortality.Results::During a mean follow-up of 7.10 years, we confirmed 237 death events related to cancer. The multivariable-adjusted hazard ratio (HR) for cancer mortality was 1.32 (95% confidence interval [CI]: 1.01-1.75) in patients with TIR ≤70% compared with those with TIR >70%. When TIR was considered as a continuous variable, the multivariable-adjusted HR for cancer mortality associated with each 10% decrease in TIR was 1.07 (95% CI: 1.02-1.14). In the site-specific analysis, a significant association between TIR as a continuous variable and the risk of hepatocellular cancer was found (HR: 1.24; 95% CI: 1.09-1.41). However, no relationship between hemoglobin A1c and cancer mortality was observed (HR: 1.04; 95% CI: 0.97-1.10).Conclusions::The present study found an inverse association of TIR with the risk of cancer mortality among patients with type 2 diabetes. New evidence of TIR was added into the clinical practice that TIR may be an optimal target of glycemic control among patients with type 2 diabetes.
文献关键词:
Time in range;HbA1c;Type 2 diabetes;Cancer mortality;Cohort study;Hepatocellular cancer
作者姓名:
Shen Yun;Wang Chunfang;Wang Yaxin;Lu Jingyi;Chen Lei;Zhang Lei;Lu Wei;Zhu Wei;Hu Gang;Xia Tian;Zhou Jian
作者机构:
Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai 200233, China;Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA;Division of Vital Statistics, Institute of Health Information, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China;Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
引用格式:
[1]Shen Yun;Wang Chunfang;Wang Yaxin;Lu Jingyi;Chen Lei;Zhang Lei;Lu Wei;Zhu Wei;Hu Gang;Xia Tian;Zhou Jian-.Association between time in range and cancer mortality among patients with type 2 diabetes: a prospective cohort study)[J].中华医学杂志(英文版),2022(03):288-294
A类:
B类:
Association,between,range,cancer,mortality,among,patients,type,diabetes,cohort,study,Background,Little,was,known,about,association,TIR,above,TAR,below,TBR,We,aimed,investigate,risk,Methods,total,were,prospectively,recruited,Shanghai,China,measured,continuous,glucose,monitoring,baseline,defined,average,percentage,target,during,period,Cox,proportion,hazard,regression,analysis,used,determine,Results,During,mean,follow,up,years,confirmed,death,events,related,multivariable,adjusted,ratio,confidence,interval,compared,those,When,considered,associated,each,decrease,In,site,specific,significant,hepatocellular,found,However,relationship,hemoglobin,observed,Conclusions,present,inverse,New,evidence,added,into,clinical,practice,that,may,optimal,glycemic,control,Time,HbA1c,Type,Cancer,Cohort,Hepatocellular
AB值:
0.434166
相似文献
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Post-discharge mortality in the first wave of COVID-19 in Turkey
Fusun Fakili;Pelin Duru Cetinkaya;Oya Baydar;Serap Argun Baris;Nurdan Kokturk;Seval Kul;Oguz Karcioglu;Pinar Aysert Yildiz;Ilim Irmak;Yonca Sekibag;Emel Azak;Sait Mulamahmutoglu;Caglar Cuhadaroglu;Bugra Kerget;Burcu Baran Ketencioglu;Hasan Selcuk Ozger;Gulcihan Ozkan;Zeynep Ture;Merve Ercelik;Tansu Ulukavak Ciftci;Ozlem Alici;Esra Nurlu Temel;Ozlem Ataoglu;Neslihan Kose;Muge Meltem Tor;Gulsah Gunluoglu;Sedat Altin;Onder Ozturk;Pinar Yildiz Gulhan;Ilknur Basyigit;Hasim Boyaci;I.Kivilcim Oguzulgen;Sermin Borekci;Bilun Gemicioglu;Ismail Hanta;Hacer Kuzu Okur;Gulseren Sagcan;Metin Akgun;Ali Fuat Kalyoncu;Oya Itil;Hasan Bayram-Department of Pulmonary Medicine,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,University of Health Sciences,Adana City Training and Research Hospital,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Cukurova University,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Kocaeli University,Kocaeli,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Biostatistics,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,Halil Sivgin Cubuk State Hospital,Ankara,Turkey;Department of Infectious Disease,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Hacettepe University,Ankara,Turkey;Department of Pulmonary Medicine,Cerrahpasa Faculty of Medicine,Istanbul University-Cerrahpasa,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Kocaeli University,Kocaeli Turkey;Department of Pulmonary Medicine,Altunizade Acibadem Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Ataturk University,Erzurum,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Erciyes University,Kayseri,Turkey;Department of Pulmonary Medicine,Maslak Acibadem Hospital,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Erciyes University,Kayseri,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Duzce University,Duzce,Turkey;Department of Infectious Disease,Faculty of Medicine,Turkiye Gazetesi Private Hospital,Istanbul,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Bilecik Training and Research Hospital,Bilecik,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Zonguldak Bulent Ecevit University,Zonguldak,Turkey;Department of Pulmonary Medicine,University of Health Science,Yedikule Chest Diseases and Chest Surgery Training and Research Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey
Coupling radiomics analysis of CT image with diversification of tumor ecosystem:A new insight to overall survival in stage Ⅰ-Ⅲ colorectal cancer
Yanqi Huang;Lan He;Zhenhui Li;Xin Chen;Chu Han;Ke Zhao;Yuan Zhang;Jinrong Qu;Yun Mao;Changhong Liang;Zaiyi Liu-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Radiology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center,Kunming 650118,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Department of Radiology,the Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450003,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
Association of baseline hemoglobin A1c levels with bleeding in patients with non-ST-segment elevation acute coronary syndrome underwent percutaneous coronary intervention:insights of a multicenter cohort study from China
Hua-Lin FAN;Li-Huan ZENG;Peng-Yuan CHEN;Yuan-Hui LIU;Chong-Yang DUAN;Wen-Fei HE;Ning TAN;Ji-Yan CHEN;Peng-Cheng HE-Department of Cardiology,School of Medicine,South China University of Technology,Guangzhou,China;Department of Cardiology,Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;The Second School of Clinical Medicine,Southern Medical University,Guangzhou,China;Department of Cardiology,the Second People's Hospital of Nanhai District,Guangdong Provincial People's Hospital's Nanhai Hospital,Foshan,China;De-partment of Biostatistics,School of Public Health,Southern Medical University,Guangzhou,China;Department of Cardiology,Heyuan People's Hospital,Heyuan,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。